Jingyue Announces Commitments Made During IPO Listing and Their Subsequent Execution Status

Jingyue announced the commitments made during its IPO listing and their execution status as of the end of Q1 2026. As of March 31, 2026, no events related to the commitments have occurred, confirming their proper fulfillment.
財務報告NQ 0/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: April 7, 2026 at 09:00
  • 🔍 Collected: April 8, 2026 at 08:00 (23h 0m after Published)
  • 🤖 AI Analyzed: April 19, 2026 at 03:06 (259h 6m after Collected)
1. Fact date: 115/04/07
2. Company Name: Jingyue Biotechnology Co., Ltd.
3. Relationship with the Company: Parent Company
4. Mutual Shareholding Ratio: Not applicable
5. Reason for Occurrence:
In accordance with the regulations of the Taiwan Stock Exchange Corporation's letter Tai-Zheng Shang-Zi No. 0990000468 dated January 8, 1999, this announcement reports on the commitments made by the company at the time of its initial public offering and their execution status for the first quarter of 2026.
6. Countermeasures:
Commitment: If the financial reports of the company's significant subsidiaries are audited and certified by other accountants, and based on which investment gains or consolidated financial reports are recognized, the company's certifying accountant shall issue a report that does not mention the audit opinion of other accountants on the financial statements.
Subsequent execution status: As of 3/31/115, the aforementioned situation has not occurred.
7. Other matters to be noted (If the subject of the event or resolution is a publicly issued company or above, this major information also meets the criteria of Article 7, Item 9 of the Regulations Governing the Enforcement of the Securities Transaction Act concerning significant impact on shareholder rights or stock prices): None
Keyword: Major Information